Financial/Business, OEM News

CONMED Completes Acquisition of In2Bones Global

Acquisition is a strategic extension of CONMED’s Orthopedic portfolio.

Author Image

By: Charlie Sternberg

Associate Editor

CONMED Corporation has completed its previously announced acquisition of privately-held In2Bones Global Inc.
 
Headquartered in Memphis, Tennessee, In2Bones is a global developer, manufacturer, and distributor of medical devices for the treatment of disorders and injuries of the upper (hand, wrist, elbow) and lower (foot and ankle) extremities. The company’s comprehensive product portfolio includes implants, fracture systems, biologics, and related hardware.
 
The transaction is being financed through a combination of the net proceeds of the company’s 2.25% convertible notes, which were issued on June 6, 2022, borrowings under the Company’s amended and restated credit facility, and cash on hand. The company will provide additional guidance regarding the impact of the transaction on 2022 financial results when it reports second quarter financial results in late July.

Keep Up With Our Content. Subscribe To Orthopedic Design & Technology Newsletters